Recent Advances in Graphene-Based Field-Effect Transistor Biosensors for Disease Biomarker Detection and Clinical Prospects
Biosensors · 26.03.2026 · 16 (4) · 190
DOI: 10.3390/bios16040190 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biosensors, online erschienen am 26.03.2026. Verfasst von Deeksha Nagpal und 5 weiteren Autor:innen. Beteiligte Einrichtung: University Centre for Research and Development, Chandigarh University, Mohali 140413, India. Hauptthemen laut MEDLINE: Biosensing Techniques, Graphite, Biomarkers, Transistors, Electronic. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 103 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Northern Illinois University, University of Texas Rio Grande Valley.
Abstract (Originalsprache)
Field-effect transistor (FET) biosensors using graphene have become one of the most promising biosensing platforms for the early diagnosis of diseases with features such as high sensitivity, label-free detection and application compatibility with point-of-care systems. Herein, we critically discuss recent advances in graphene FET (GFET) biosensor development toward clinically relevant biomarkers associated with representative diseases including cancer, neurodegenerative disease, infectious disease, and inflammatory conditions. Recent progress was reviewed to evaluate GFET architectures, surface functionalization methods, and detection quality. The biomarkers explored were clusterin in Alzheimer’s disease, thrombin in coagulopathy, estrogen receptor α (ER-α) in breast cancer, Carcinoembryonic antigen in lung cancer, microRNAs for malignant tumors, exosomes derived from HepG2 for the hepatocellular carcinoma (HCC) cell line, interleukin-6 (IL-6) for chronic obstructive pulmonary disease (COPD), Polyclonal antibodies and antigens (P24) for HIV and prostate-specific antigen for prostate cancer. The developed devices demonstrate ultralow detection limits at femtomolar to attomolar concentrations with the aid of designed antibodies, aptamers and nanomaterials. Herein, this review presents the sensing mechanisms and biomedical application of various GFET platforms, focusing on their emerging potential as next-generation platforms for rapid, non-invasive and point-of-care diagnostics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University Centre for Research and Development, Chandigarh University, Mohali 140413, India.
- Department of Electrical Engineering, College of Engineering and Engineering Technology, Northern Illinois University, Dekalb, IL 60115, USA.
- Department of Health and Biomedical Sciences, University of Texas Rio Grande Valley, Brownsville, TX 78521, USA.
- Department of Applied Sciences, National Institute of Technical Teachers Training and Research, Chandigarh 160019, India.
ORCID-Profile: Deeksha Nagpal, Anup Singh, Abijeet Singh Mehta, Ashok Kumar, Vinay Budhraja
Förderung
- Northern Illinois University
- University of Texas Rio Grande Valley
Zitieren
APA
Nagpal, D., Singh, A., Link, J., Mehta, A. S., Kumar, A., & Budhraja, V. (2026). Recent Advances in Graphene-Based Field-Effect Transistor Biosensors for Disease Biomarker Detection and Clinical Prospects. Biosensors, 16(4), 190. https://doi.org/10.3390/bios16040190
Vancouver
Nagpal D, Singh A, Link J, Mehta AS, Kumar A, Budhraja V. Recent Advances in Graphene-Based Field-Effect Transistor Biosensors for Disease Biomarker Detection and Clinical Prospects. Biosensors. 2026;16(4):190. doi:10.3390/bios16040190
BibTeX
@article{Nagpal2026,
author = {Nagpal, Deeksha and Singh, Anup and Link, John and Mehta, Abijeet Singh and Kumar, Ashok and Budhraja, Vinay},
title = {Recent Advances in Graphene-Based Field-Effect Transistor Biosensors for Disease Biomarker Detection and Clinical Prospects},
journal = {Biosensors},
year = {2026},
volume = {16},
number = {4},
pages = {190},
doi = {10.3390/bios16040190}
}
EUVIMED